Steven Cohen's ABBV Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 359.4K shares of AbbVie Inc. (ABBV) worth $83.23 M, representing 0.14% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2015, adding 1.1M shares. Largest reduction occurred in Q2 2020, reducing 1.1M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2014 | +184,300 | New Buy | 184,300 | $57.76 |
| Q4 2014 | -184,300 | Sold Out | 184,300 | $0.00 |
| Q1 2015 | +144,800 | New Buy | 144,800 | $58.54 |
| Q2 2015 | +1.1 M | Add 760.15% | 1.25 M | $67.19 |
| Q3 2015 | -1.25 M | Sold Out | 1.25 M | $0.00 |
| Q4 2016 | +1.14 M | New Buy | 1.14 M | $62.62 |
| Q1 2017 | -196,266 | Reduce 17.27% | 940,300 | $65.16 |
| Q2 2017 | -770,300 | Reduce 81.92% | 170,000 | $72.51 |
| Q3 2017 | -170,000 | Sold Out | 170,000 | $0.00 |
| Q1 2019 | +70,130 | New Buy | 70,130 | $80.59 |
| Q2 2019 | +814,776 | Add 1161.81% | 884,906 | $72.72 |
| Q3 2019 | -884,906 | Sold Out | 884,906 | $0.00 |
| Q1 2020 | +1.39 M | New Buy | 1.39 M | $76.19 |
| Q2 2020 | -1.14 M | Reduce 82.17% | 248,028 | $98.18 |
| Q3 2020 | -160,627 | Reduce 64.76% | 87,401 | $87.58 |
| Q4 2020 | -32,955 | Reduce 37.71% | 54,446 | $107.15 |
| Q1 2021 | -54,446 | Sold Out | 54,446 | $0.00 |
| Q1 2023 | +1.03 M | New Buy | 1.03 M | $159.37 |
| Q2 2023 | -407,901 | Reduce 39.64% | 620,999 | $134.73 |
| Q3 2023 | +400,875 | Add 64.55% | 1.02 M | $149.06 |
| Q4 2023 | -234,374 | Reduce 22.94% | 787,500 | $154.97 |
| Q1 2024 | -745,362 | Reduce 94.65% | 42,138 | $182.10 |
| Q2 2024 | -42,138 | Sold Out | 42,138 | $0.00 |
| Q2 2025 | +5,210 | New Buy | 5,210 | $185.62 |
| Q3 2025 | +354,234 | Add 6799.12% | 359,444 | $231.54 |
Steven Cohen's AbbVie Investment FAQs
Steven Cohen first purchased AbbVie Inc. (ABBV) in Q3 2014, acquiring 184,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AbbVie Inc. (ABBV) for 45 quarters since Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to AbbVie Inc. (ABBV) was in Q1 2020, adding 1,390,906 shares worth $105.97 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 359,444 shares of AbbVie Inc. (ABBV), valued at approximately $83.23 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.14% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in AbbVie Inc. (ABBV) was 1,390,906 shares, as reported at the end of Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.